Healthcare

Clinical Trials / Studies

Master
Content

Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.

Content

View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.

Search for Clinical Trials

A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
  • Cancer - Breast
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone. Tucatinib is a type of drug…
  • Cancer - Breast
  • Cancer - Metastatic
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
  • Cancer - Breast
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
  • Cancer - Breast
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
  • Cancer - Breast
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
  • Cancer - Breast
  • Cancer - Metastatic
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
  • Digestive System
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
  • Digestive System